| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 19 | 2014 | 206 | 2.020 |
Why?
|
| Lung Neoplasms | 29 | 2020 | 1172 | 1.940 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 14 | 2020 | 300 | 1.910 |
Why?
|
| Carcinoma, Renal Cell | 18 | 2014 | 110 | 1.880 |
Why?
|
| Chromosomes, Human, Pair 3 | 34 | 2014 | 56 | 1.840 |
Why?
|
| Receptors, Cell Surface | 11 | 2014 | 248 | 1.190 |
Why?
|
| Neuropilin-2 | 4 | 2022 | 19 | 1.080 |
Why?
|
| Translocation, Genetic | 19 | 2014 | 74 | 1.020 |
Why?
|
| Homeodomain Proteins | 9 | 2016 | 157 | 0.870 |
Why?
|
| Cholesterol | 3 | 2012 | 331 | 0.760 |
Why?
|
| Transcription Factors | 10 | 2016 | 753 | 0.730 |
Why?
|
| Cadherins | 6 | 2010 | 93 | 0.660 |
Why?
|
| Quinazolines | 4 | 2009 | 70 | 0.660 |
Why?
|
| Membrane Proteins | 6 | 2009 | 617 | 0.620 |
Why?
|
| Chromosomes, Artificial, Yeast | 14 | 2002 | 16 | 0.610 |
Why?
|
| Chromosome Mapping | 25 | 2009 | 188 | 0.600 |
Why?
|
| Antineoplastic Agents | 7 | 2020 | 1070 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 756 | 0.570 |
Why?
|
| Protein Kinase Inhibitors | 4 | 2020 | 331 | 0.550 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2010 | 89 | 0.530 |
Why?
|
| Tumor Cells, Cultured | 20 | 2016 | 852 | 0.500 |
Why?
|
| Carcinoma, Small Cell | 6 | 1999 | 53 | 0.490 |
Why?
|
| Transforming Growth Factor beta | 1 | 2017 | 384 | 0.470 |
Why?
|
| Chromosome Deletion | 7 | 1997 | 41 | 0.460 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2005 | 194 | 0.460 |
Why?
|
| Drosophila Proteins | 2 | 2005 | 44 | 0.450 |
Why?
|
| Chromosomes, Human, Pair 8 | 11 | 2014 | 54 | 0.430 |
Why?
|
| Restriction Mapping | 5 | 2002 | 85 | 0.420 |
Why?
|
| Gene Amplification | 3 | 2009 | 71 | 0.410 |
Why?
|
| Chromosomes, Human, Pair 12 | 5 | 1996 | 16 | 0.370 |
Why?
|
| Sterols | 1 | 2010 | 13 | 0.360 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2017 | 710 | 0.360 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 181 | 0.350 |
Why?
|
| Humans | 84 | 2022 | 68549 | 0.350 |
Why?
|
| Blotting, Western | 7 | 2017 | 954 | 0.340 |
Why?
|
| Genetic Markers | 15 | 1997 | 144 | 0.340 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2009 | 5 | 0.340 |
Why?
|
| Molecular Sequence Data | 16 | 2014 | 1446 | 0.340 |
Why?
|
| Genes, myc | 1 | 2009 | 26 | 0.340 |
Why?
|
| Genes, Tumor Suppressor | 6 | 2009 | 61 | 0.330 |
Why?
|
| Acid Anhydride Hydrolases | 6 | 2014 | 13 | 0.330 |
Why?
|
| Lipid Metabolism | 1 | 2010 | 186 | 0.330 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 8 | 2016 | 22 | 0.310 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 5 | 2002 | 23 | 0.310 |
Why?
|
| Cell Line, Tumor | 10 | 2017 | 1851 | 0.310 |
Why?
|
| Neoplasm Proteins | 7 | 2014 | 307 | 0.310 |
Why?
|
| Sirolimus | 2 | 2007 | 118 | 0.310 |
Why?
|
| Liposarcoma | 3 | 1992 | 13 | 0.310 |
Why?
|
| ErbB Receptors | 4 | 2016 | 239 | 0.300 |
Why?
|
| DNA | 8 | 2002 | 597 | 0.300 |
Why?
|
| Amino Acid Sequence | 7 | 2017 | 1082 | 0.300 |
Why?
|
| DNA-Binding Proteins | 4 | 2009 | 700 | 0.280 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2020 | 332 | 0.280 |
Why?
|
| Obesity | 2 | 2012 | 1074 | 0.270 |
Why?
|
| Proteins | 6 | 2003 | 473 | 0.270 |
Why?
|
| Chromosomes, Fungal | 4 | 2002 | 14 | 0.260 |
Why?
|
| Animals | 22 | 2022 | 20880 | 0.260 |
Why?
|
| Ovarian Neoplasms | 4 | 2009 | 267 | 0.260 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 67 | 0.250 |
Why?
|
| Chromosome Fragility | 7 | 1998 | 10 | 0.250 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 123 | 0.240 |
Why?
|
| Cell Line | 11 | 2014 | 1752 | 0.230 |
Why?
|
| Blotting, Southern | 6 | 2001 | 67 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 4 | 2009 | 290 | 0.230 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2016 | 135 | 0.220 |
Why?
|
| Mutation | 9 | 2016 | 1213 | 0.210 |
Why?
|
| Ligases | 1 | 2002 | 6 | 0.210 |
Why?
|
| Kidney | 2 | 2006 | 945 | 0.200 |
Why?
|
| Drosophila | 3 | 2010 | 37 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 16 | 2 | 1992 | 18 | 0.200 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 2017 | 230 | 0.200 |
Why?
|
| Cell Proliferation | 5 | 2020 | 1174 | 0.190 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 2 | 2010 | 5 | 0.180 |
Why?
|
| Acrylamides | 1 | 2020 | 12 | 0.180 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 5 | 2010 | 13 | 0.180 |
Why?
|
| Aniline Compounds | 1 | 2020 | 52 | 0.180 |
Why?
|
| Up-Regulation | 5 | 2013 | 682 | 0.180 |
Why?
|
| Base Sequence | 11 | 2014 | 1015 | 0.180 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 5 | 1997 | 37 | 0.180 |
Why?
|
| Lipids | 2 | 2012 | 298 | 0.170 |
Why?
|
| Repressor Proteins | 2 | 2010 | 182 | 0.170 |
Why?
|
| Signal Transduction | 5 | 2007 | 2689 | 0.160 |
Why?
|
| Cloning, Molecular | 8 | 2006 | 357 | 0.160 |
Why?
|
| Female | 25 | 2022 | 38021 | 0.160 |
Why?
|
| Coleoptera | 1 | 2018 | 8 | 0.160 |
Why?
|
| Chromosome Aberrations | 5 | 1994 | 86 | 0.160 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 2001 | 285 | 0.160 |
Why?
|
| In Situ Hybridization, Fluorescence | 9 | 2000 | 144 | 0.160 |
Why?
|
| DNA, Recombinant | 3 | 2001 | 25 | 0.150 |
Why?
|
| RNA Interference | 2 | 2017 | 266 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases | 3 | 1998 | 56 | 0.150 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2002 | 172 | 0.150 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 1997 | 8 | 0.150 |
Why?
|
| Neovascularization, Pathologic | 3 | 2010 | 183 | 0.140 |
Why?
|
| Mice | 7 | 2022 | 8474 | 0.140 |
Why?
|
| Transplantation, Heterologous | 1 | 2017 | 122 | 0.140 |
Why?
|
| Biomarkers, Tumor | 3 | 2012 | 508 | 0.140 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2004 | 411 | 0.140 |
Why?
|
| Genetic Vectors | 2 | 2001 | 311 | 0.140 |
Why?
|
| Gene Expression Profiling | 3 | 2010 | 498 | 0.140 |
Why?
|
| Cytoskeletal Proteins | 2 | 2010 | 108 | 0.130 |
Why?
|
| DNA Primers | 6 | 2005 | 302 | 0.130 |
Why?
|
| Genome, Human | 3 | 1992 | 62 | 0.130 |
Why?
|
| Endoplasmic Reticulum | 2 | 2009 | 148 | 0.130 |
Why?
|
| Genomic Library | 2 | 1992 | 18 | 0.130 |
Why?
|
| Survival Analysis | 1 | 2017 | 714 | 0.130 |
Why?
|
| Disease Progression | 2 | 2017 | 1037 | 0.120 |
Why?
|
| Inverted Repeat Sequences | 2 | 2014 | 4 | 0.120 |
Why?
|
| RNA, Small Interfering | 3 | 2016 | 434 | 0.120 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2010 | 14 | 0.120 |
Why?
|
| Histone Deacetylase Inhibitors | 3 | 2011 | 116 | 0.120 |
Why?
|
| RNA, Messenger | 5 | 2016 | 1663 | 0.120 |
Why?
|
| COP9 Signalosome Complex | 2 | 2005 | 2 | 0.120 |
Why?
|
| Polymorphism, Genetic | 2 | 1997 | 301 | 0.120 |
Why?
|
| Cricetinae | 5 | 2010 | 262 | 0.110 |
Why?
|
| Gene Library | 2 | 1993 | 68 | 0.110 |
Why?
|
| Male | 18 | 2017 | 37283 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 2 | 2010 | 18 | 0.110 |
Why?
|
| Hydroxamic Acids | 2 | 2011 | 84 | 0.110 |
Why?
|
| Refractometry | 1 | 2012 | 23 | 0.110 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2013 | 126 | 0.110 |
Why?
|
| Immunoassay | 1 | 2012 | 64 | 0.110 |
Why?
|
| Cholesterol Esters | 1 | 2012 | 26 | 0.110 |
Why?
|
| Cricetulus | 4 | 2010 | 98 | 0.110 |
Why?
|
| Glycogen | 1 | 2012 | 27 | 0.110 |
Why?
|
| Mevalonic Acid | 1 | 2012 | 27 | 0.110 |
Why?
|
| Rats, Nude | 2 | 2009 | 5 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2010 | 71 | 0.100 |
Why?
|
| Biosensing Techniques | 1 | 2012 | 51 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2022 | 1533 | 0.100 |
Why?
|
| Lipoma | 1 | 1992 | 24 | 0.100 |
Why?
|
| Genetics, Medical | 2 | 2002 | 17 | 0.100 |
Why?
|
| Aged | 7 | 2017 | 14842 | 0.100 |
Why?
|
| Flow Cytometry | 2 | 2009 | 489 | 0.100 |
Why?
|
| Benzamides | 2 | 2009 | 156 | 0.100 |
Why?
|
| Zinc Fingers | 1 | 1990 | 17 | 0.100 |
Why?
|
| Histone Deacetylases | 2 | 2009 | 99 | 0.090 |
Why?
|
| Adult | 9 | 2017 | 21379 | 0.090 |
Why?
|
| Genes | 1 | 1990 | 86 | 0.090 |
Why?
|
| CHO Cells | 2 | 2010 | 161 | 0.090 |
Why?
|
| Nondisjunction, Genetic | 1 | 2010 | 1 | 0.090 |
Why?
|
| Meiosis | 1 | 2010 | 5 | 0.090 |
Why?
|
| Hemangiosarcoma | 1 | 2010 | 23 | 0.090 |
Why?
|
| Middle Aged | 9 | 2017 | 21119 | 0.090 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 50 | 0.090 |
Why?
|
| Protein Binding | 3 | 2010 | 1027 | 0.090 |
Why?
|
| Sterol Regulatory Element Binding Proteins | 1 | 2010 | 1 | 0.090 |
Why?
|
| Estrone | 1 | 2010 | 9 | 0.090 |
Why?
|
| Gene Expression Regulation | 3 | 2005 | 1293 | 0.090 |
Why?
|
| Lactams, Macrocyclic | 1 | 2009 | 7 | 0.090 |
Why?
|
| Carcinoma | 1 | 2011 | 215 | 0.090 |
Why?
|
| Benzoquinones | 1 | 2009 | 13 | 0.090 |
Why?
|
| Dysgerminoma | 1 | 2009 | 9 | 0.090 |
Why?
|
| Adiponectin | 1 | 2010 | 52 | 0.090 |
Why?
|
| Protein Stability | 1 | 2010 | 89 | 0.090 |
Why?
|
| Genetic Linkage | 7 | 1996 | 90 | 0.090 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2010 | 65 | 0.090 |
Why?
|
| Ubiquitination | 1 | 2010 | 85 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 58 | 0.090 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2009 | 24 | 0.090 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 34 | 0.090 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2009 | 46 | 0.090 |
Why?
|
| DNA Probes | 7 | 1996 | 57 | 0.090 |
Why?
|
| Leptin | 1 | 2010 | 80 | 0.090 |
Why?
|
| Molecular Chaperones | 1 | 2010 | 81 | 0.080 |
Why?
|
| Oncogenes | 2 | 1989 | 71 | 0.080 |
Why?
|
| Ubiquitin | 1 | 2009 | 74 | 0.080 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 4843 | 0.080 |
Why?
|
| Cell Cycle | 2 | 2007 | 312 | 0.080 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2010 | 282 | 0.080 |
Why?
|
| Protein Kinases | 2 | 2007 | 122 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2011 | 467 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2011 | 332 | 0.080 |
Why?
|
| Bronchi | 2 | 2000 | 59 | 0.080 |
Why?
|
| Leukemia, Myeloid | 2 | 2004 | 39 | 0.080 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2007 | 118 | 0.080 |
Why?
|
| Melanoma | 1 | 2011 | 335 | 0.080 |
Why?
|
| Pyridines | 1 | 2009 | 261 | 0.080 |
Why?
|
| Y Chromosome | 1 | 1987 | 5 | 0.080 |
Why?
|
| Turner Syndrome | 1 | 1987 | 10 | 0.080 |
Why?
|
| Cell Division | 2 | 2006 | 541 | 0.080 |
Why?
|
| Mosaicism | 1 | 1987 | 21 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2010 | 2673 | 0.070 |
Why?
|
| G2 Phase | 1 | 2006 | 26 | 0.070 |
Why?
|
| Chromosomes, Artificial, Bacterial | 2 | 2007 | 8 | 0.070 |
Why?
|
| Disease Susceptibility | 1 | 2007 | 179 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2010 | 597 | 0.070 |
Why?
|
| Phenotype | 2 | 2010 | 946 | 0.070 |
Why?
|
| Apoptosis | 2 | 2011 | 1641 | 0.070 |
Why?
|
| Azacitidine | 1 | 1986 | 20 | 0.070 |
Why?
|
| X Chromosome | 1 | 1986 | 28 | 0.070 |
Why?
|
| Sequence Analysis, DNA | 4 | 2014 | 208 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 250 | 0.070 |
Why?
|
| Cyclooxygenase 2 | 1 | 2006 | 160 | 0.070 |
Why?
|
| Gene Deletion | 2 | 1997 | 235 | 0.070 |
Why?
|
| Dinoprostone | 1 | 2006 | 110 | 0.060 |
Why?
|
| Yeasts | 1 | 2005 | 15 | 0.060 |
Why?
|
| Phosphorylation | 3 | 2020 | 1200 | 0.060 |
Why?
|
| Point Mutation | 1 | 2005 | 97 | 0.060 |
Why?
|
| Drug Synergism | 1 | 2005 | 260 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 1995 | 20 | 0.060 |
Why?
|
| Genes, Homeobox | 1 | 2004 | 15 | 0.060 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 2 | 2020 | 57 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 214 | 0.060 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2004 | 100 | 0.060 |
Why?
|
| Rats | 2 | 2009 | 5300 | 0.060 |
Why?
|
| Neoplasms | 2 | 2001 | 1664 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2000 | 624 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2020 | 331 | 0.050 |
Why?
|
| Alleles | 3 | 2007 | 386 | 0.050 |
Why?
|
| AT Rich Sequence | 2 | 2014 | 5 | 0.050 |
Why?
|
| Wings, Animal | 1 | 2002 | 6 | 0.050 |
Why?
|
| Neuropilin-1 | 1 | 2022 | 4 | 0.050 |
Why?
|
| von Hippel-Lindau Disease | 2 | 1994 | 7 | 0.050 |
Why?
|
| Loss of Heterozygosity | 2 | 2000 | 25 | 0.050 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2020 | 108 | 0.050 |
Why?
|
| Bacteriophage lambda | 1 | 2002 | 7 | 0.050 |
Why?
|
| 3T3 Cells | 1 | 2002 | 124 | 0.050 |
Why?
|
| Sepharose | 1 | 2002 | 18 | 0.050 |
Why?
|
| Peptide Hydrolases | 1 | 2002 | 82 | 0.050 |
Why?
|
| COS Cells | 1 | 2002 | 155 | 0.050 |
Why?
|
| Muscle Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
| Schizosaccharomyces | 1 | 2002 | 31 | 0.050 |
Why?
|
| Cell Movement | 2 | 2020 | 630 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 358 | 0.050 |
Why?
|
| Electrophoresis, Agar Gel | 3 | 1991 | 32 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 2 | 2005 | 261 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 1 | 2002 | 322 | 0.050 |
Why?
|
| Protein Isoforms | 1 | 2022 | 246 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2001 | 62 | 0.050 |
Why?
|
| Lymphocytes | 4 | 2009 | 228 | 0.050 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2002 | 216 | 0.050 |
Why?
|
| Syndactyly | 2 | 1991 | 4 | 0.050 |
Why?
|
| Facial Bones | 2 | 1991 | 10 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 2 | 2016 | 196 | 0.050 |
Why?
|
| Karyotyping | 6 | 1994 | 74 | 0.050 |
Why?
|
| Microsatellite Repeats | 2 | 1997 | 40 | 0.050 |
Why?
|
| A549 Cells | 1 | 2020 | 50 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 6 | 1997 | 492 | 0.050 |
Why?
|
| Skull | 2 | 1991 | 63 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2013 | 294 | 0.050 |
Why?
|
| Transfection | 3 | 2007 | 782 | 0.040 |
Why?
|
| Lung | 1 | 2005 | 849 | 0.040 |
Why?
|
| Chromosome Fragile Sites | 6 | 1998 | 7 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2001 | 237 | 0.040 |
Why?
|
| Homozygote | 2 | 1997 | 119 | 0.040 |
Why?
|
| Proteolysis | 1 | 2020 | 97 | 0.040 |
Why?
|
| Sequence Tagged Sites | 2 | 1997 | 2 | 0.040 |
Why?
|
| Hybrid Cells | 6 | 1996 | 18 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 369 | 0.040 |
Why?
|
| Gene Duplication | 1 | 1998 | 12 | 0.040 |
Why?
|
| Immunohistochemistry | 3 | 2009 | 1174 | 0.040 |
Why?
|
| DNA, Neoplasm | 3 | 1997 | 95 | 0.040 |
Why?
|
| DNA Restriction Enzymes | 3 | 1987 | 49 | 0.040 |
Why?
|
| Methylation | 2 | 1990 | 56 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 1998 | 22 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2020 | 791 | 0.040 |
Why?
|
| North America | 1 | 2018 | 111 | 0.040 |
Why?
|
| Chromosome Banding | 5 | 1989 | 24 | 0.040 |
Why?
|
| Spinocerebellar Degenerations | 1 | 1997 | 1 | 0.040 |
Why?
|
| Trinucleotide Repeats | 1 | 1997 | 8 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1987 | 95 | 0.040 |
Why?
|
| Blepharophimosis | 1 | 1997 | 2 | 0.040 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1997 | 8 | 0.040 |
Why?
|
| Blepharoptosis | 1 | 1997 | 7 | 0.040 |
Why?
|
| Propionates | 1 | 1997 | 21 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 1999 | 215 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1997 | 23 | 0.040 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 201 | 0.040 |
Why?
|
| Cerebellar Ataxia | 1 | 1996 | 8 | 0.040 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1996 | 10 | 0.040 |
Why?
|
| Rhabdomyosarcoma | 1 | 1996 | 36 | 0.040 |
Why?
|
| Troponin C | 1 | 1996 | 2 | 0.030 |
Why?
|
| Muscle Fibers, Slow-Twitch | 1 | 1996 | 7 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2007 | 150 | 0.030 |
Why?
|
| Nerve Growth Factors | 1 | 1996 | 75 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2007 | 147 | 0.030 |
Why?
|
| Neuroblastoma | 1 | 1996 | 109 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2009 | 447 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 209 | 0.030 |
Why?
|
| DNA, Satellite | 1 | 1994 | 4 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 1 | 0.030 |
Why?
|
| Transcription, Genetic | 2 | 2009 | 562 | 0.030 |
Why?
|
| HeLa Cells | 2 | 2009 | 237 | 0.030 |
Why?
|
| Angiomatosis | 2 | 1994 | 5 | 0.030 |
Why?
|
| Gene Frequency | 1 | 1994 | 207 | 0.030 |
Why?
|
| Leukemia | 1 | 1993 | 117 | 0.030 |
Why?
|
| Silicon | 1 | 2012 | 20 | 0.030 |
Why?
|
| Miniaturization | 1 | 2012 | 21 | 0.030 |
Why?
|
| Genotype | 2 | 2010 | 785 | 0.030 |
Why?
|
| Crystallization | 1 | 2012 | 57 | 0.030 |
Why?
|
| Software | 1 | 1995 | 418 | 0.030 |
Why?
|
| Fragile X Syndrome | 2 | 1998 | 17 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 1992 | 9 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2012 | 144 | 0.030 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 1992 | 9 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1995 | 621 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 1993 | 138 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2012 | 121 | 0.030 |
Why?
|
| Apolipoproteins | 1 | 1992 | 51 | 0.030 |
Why?
|
| Wnt Proteins | 2 | 2003 | 57 | 0.030 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 235 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2011 | 29 | 0.020 |
Why?
|
| Lactones | 1 | 2011 | 64 | 0.020 |
Why?
|
| Child | 3 | 2010 | 6401 | 0.020 |
Why?
|
| Equipment Design | 1 | 2012 | 500 | 0.020 |
Why?
|
| Human Genome Project | 1 | 1991 | 4 | 0.020 |
Why?
|
| Pyrroles | 1 | 2011 | 83 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 304 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 1033 | 0.020 |
Why?
|
| Chromosome Breakage | 1 | 2010 | 6 | 0.020 |
Why?
|
| Spermatogenesis | 1 | 2010 | 7 | 0.020 |
Why?
|
| Health | 1 | 2010 | 26 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2010 | 47 | 0.020 |
Why?
|
| Spermatozoa | 1 | 2010 | 75 | 0.020 |
Why?
|
| Exons | 2 | 2001 | 122 | 0.020 |
Why?
|
| ras Proteins | 1 | 2010 | 102 | 0.020 |
Why?
|
| Dogs | 1 | 2010 | 490 | 0.020 |
Why?
|
| Viral Envelope Proteins | 1 | 2009 | 43 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 1989 | 18 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2010 | 320 | 0.020 |
Why?
|
| Response Elements | 1 | 2009 | 29 | 0.020 |
Why?
|
| Prognosis | 2 | 2006 | 2093 | 0.020 |
Why?
|
| Ovary | 1 | 2009 | 99 | 0.020 |
Why?
|
| Heterozygote | 1 | 1989 | 174 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2010 | 3187 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2009 | 376 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 1 | 2007 | 30 | 0.020 |
Why?
|
| Smoking | 1 | 1996 | 1449 | 0.020 |
Why?
|
| Siblings | 1 | 2007 | 34 | 0.020 |
Why?
|
| Pedigree | 1 | 1987 | 159 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2007 | 86 | 0.020 |
Why?
|
| Erlotinib Hydrochloride | 1 | 2007 | 12 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 631 | 0.020 |
Why?
|
| Age of Onset | 2 | 1997 | 188 | 0.020 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2007 | 107 | 0.020 |
Why?
|
| Aphidicolin | 3 | 1994 | 8 | 0.020 |
Why?
|
| DNA, Fungal | 1 | 1986 | 20 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2007 | 82 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2007 | 304 | 0.020 |
Why?
|
| E-Box Elements | 1 | 2006 | 3 | 0.020 |
Why?
|
| Cell Aggregation | 1 | 2006 | 28 | 0.020 |
Why?
|
| Snail Family Transcription Factors | 1 | 2006 | 31 | 0.020 |
Why?
|
| Philadelphia Chromosome | 1 | 1986 | 7 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1986 | 92 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1986 | 272 | 0.020 |
Why?
|
| Risk | 1 | 1987 | 563 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 786 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2007 | 291 | 0.020 |
Why?
|
| Models, Genetic | 1 | 1986 | 161 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2005 | 15 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2005 | 78 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2005 | 160 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 1996 | 189 | 0.020 |
Why?
|
| Integrins | 1 | 2005 | 115 | 0.020 |
Why?
|
| CCAAT-Enhancer-Binding Protein-alpha | 1 | 2004 | 6 | 0.020 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2004 | 29 | 0.020 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 1 | 2004 | 21 | 0.020 |
Why?
|
| Inflammation | 1 | 2010 | 1030 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 258 | 0.010 |
Why?
|
| Genetic Diseases, Inborn | 2 | 1996 | 24 | 0.010 |
Why?
|
| Syndrome | 2 | 1997 | 255 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2005 | 324 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 614 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2005 | 306 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 219 | 0.010 |
Why?
|
| Lithium | 1 | 2003 | 76 | 0.010 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2003 | 64 | 0.010 |
Why?
|
| Acute Disease | 1 | 2004 | 658 | 0.010 |
Why?
|
| Catenins | 1 | 2002 | 8 | 0.010 |
Why?
|
| Polymorphism, Restriction Fragment Length | 2 | 1994 | 44 | 0.010 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2002 | 14 | 0.010 |
Why?
|
| Adolescent | 2 | 2010 | 8904 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 901 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 1465 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2001 | 5 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2005 | 493 | 0.010 |
Why?
|
| Microfilament Proteins | 1 | 2002 | 102 | 0.010 |
Why?
|
| gamma Catenin | 1 | 2001 | 11 | 0.010 |
Why?
|
| Desmoplakins | 1 | 2001 | 14 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 2002 | 274 | 0.010 |
Why?
|
| beta Catenin | 1 | 2001 | 73 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2001 | 159 | 0.010 |
Why?
|
| Cell Adhesion Molecules | 1 | 2002 | 199 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2002 | 202 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2002 | 258 | 0.010 |
Why?
|
| Cell Line, Transformed | 1 | 2000 | 100 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2002 | 524 | 0.010 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2000 | 29 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2000 | 28 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2002 | 799 | 0.010 |
Why?
|
| Fibroblasts | 2 | 1995 | 902 | 0.010 |
Why?
|
| Survival Rate | 1 | 2002 | 1055 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1999 | 67 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1999 | 89 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 1999 | 79 | 0.010 |
Why?
|
| RNA Splicing | 1 | 1998 | 32 | 0.010 |
Why?
|
| Bronchoscopy | 1 | 2000 | 147 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2000 | 231 | 0.010 |
Why?
|
| Diterpenes | 2 | 1988 | 42 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2000 | 371 | 0.010 |
Why?
|
| Ataxin-7 | 1 | 1997 | 1 | 0.010 |
Why?
|
| Genomic Imprinting | 1 | 1997 | 10 | 0.010 |
Why?
|
| Carboxy-Lyases | 1 | 1997 | 5 | 0.010 |
Why?
|
| Methylmalonyl-CoA Decarboxylase | 1 | 1997 | 2 | 0.010 |
Why?
|
| Infertility, Female | 1 | 1997 | 25 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1997 | 95 | 0.010 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1997 | 95 | 0.010 |
Why?
|
| HT29 Cells | 1 | 1997 | 42 | 0.010 |
Why?
|
| Chemoprevention | 1 | 1997 | 26 | 0.010 |
Why?
|
| Brazil | 1 | 1996 | 48 | 0.010 |
Why?
|
| United Kingdom | 1 | 1996 | 152 | 0.010 |
Why?
|
| Retinal Degeneration | 1 | 1997 | 75 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1997 | 220 | 0.010 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1996 | 20 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 1996 | 110 | 0.010 |
Why?
|
| Age Distribution | 1 | 1996 | 319 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 172 | 0.010 |
Why?
|
| Retina | 1 | 1997 | 252 | 0.010 |
Why?
|
| Species Specificity | 1 | 1996 | 302 | 0.010 |
Why?
|
| Oligonucleotide Probes | 1 | 1994 | 35 | 0.010 |
Why?
|
| Hemangioblastoma | 1 | 1994 | 6 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1994 | 22 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1994 | 26 | 0.010 |
Why?
|
| Cerebellar Neoplasms | 1 | 1994 | 17 | 0.010 |
Why?
|
| Metaphase | 1 | 1994 | 12 | 0.010 |
Why?
|
| Interphase | 1 | 1994 | 19 | 0.010 |
Why?
|
| Retinal Diseases | 1 | 1994 | 40 | 0.010 |
Why?
|
| Clone Cells | 1 | 1993 | 67 | 0.010 |
Why?
|
| Gene Expression | 1 | 1996 | 770 | 0.010 |
Why?
|
| RNA | 1 | 1993 | 171 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1996 | 2455 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 2891 | 0.010 |
Why?
|
| Risk Factors | 1 | 2000 | 5720 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1989 | 8 | 0.010 |
Why?
|
| Chromosome Disorders | 1 | 1989 | 31 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1989 | 135 | 0.000 |
Why?
|
| Chromosomes, Human, 6-12 and X | 1 | 1986 | 2 | 0.000 |
Why?
|